Cointime

Cognate BioServices

company

About

Cognate provides full development and cGMP manufacturing services to companies engaged in the development of cell-based products.

  • 101 - 250

Highlights

Funding Rounds
2
Investors
1

Details

Last Funding Type
Series Unknown
Industries
Biotechnology,Health Care,Manufacturing
Founded date
Jan 1, 2002
Number Of Employee
101 - 250
Operating Status
Active

Cognate Bioservices is a fully-integrated contract bioservices organization providing the highest level of scientific and management expertise. Cognate provides full development and cGMP manufacturing services to companies and institutions engaged in the development of cell-based products. The combination of highly experienced staff, successful track records and cGMP facilities makes Cognate one of the most qualified contract manufacturers of cell-based products in the world today.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
—
Cognate BioServices has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jan 22, 2020 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 22, 2020 Series B — 1 — — Detail
Feb 20, 2018 Series Unknown — 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Cognate BioServices is funded by 1 investors. Medivate Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Medivate Partners — Series B
Cointime
Chủ Đề
Công Ty